NYSEMKT: IGC
Igc Pharma Inc Stock Forecast, Predictions & Price Target

Analyst price target for IGC

Based on 2 analysts offering 12 month price targets for Igc Pharma Inc

Min Forecast
$3.50+866.85%
Avg Forecast
$3.88+970.44%
Max Forecast
$4.25+1,074.03%

Should I buy or sell IGC stock?

Based on 2 analysts offering ratings for Igc Pharma Inc.

Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their IGC stock forecasts and price targets.

IGC stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-03-06
lockedlocked$00.00+00.00%2025-02-24

1 of 1

IGC vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
IGC$0.37$3.88+947.30%Strong Buy
RANI$0.54$7.75+1,335.19%Strong Buy
ALXO$0.58$3.30+468.97%Strong Buy
KLTO$0.96N/AN/A
RADX$4.71$15.00+218.47%Strong Buy

Igc Pharma Stock Forecast FAQ

Is Igc Pharma Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NYSEMKT: IGC) stock is to Strong Buy IGC stock.

Out of 2 analysts, 1 (50%) are recommending IGC as a Strong Buy, 1 (50%) are recommending IGC as a Buy, 0 (0%) are recommending IGC as a Hold, 0 (0%) are recommending IGC as a Sell, and 0 (0%) are recommending IGC as a Strong Sell.

If you're new to stock investing, here's how to buy Igc Pharma stock.

What is IGC's Price Target?

According to 2 Wall Street analysts that have issued a 1 year IGC price target, the average IGC price target is $3.88, with the highest IGC stock price forecast at $4.25 and the lowest IGC stock price forecast at $3.50.

On average, Wall Street analysts predict that Igc Pharma's share price could reach $3.88 by Mar 6, 2026. The average Igc Pharma stock price prediction forecasts a potential upside of 947.3% from the current IGC share price of $0.37.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.